Journal of the American College of Cardiology

publication venue for

The Impact of Socioeconomic Status and Diagnostic Timeline on Clinical Outcomes in ATTR Cardiomyopathy.. 84:e289-e290. 2024
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program.. 84:1603-1614. 2024
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.. 84:1587-1602. 2024
Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program.. 84:1646-1662. 2024
Searching for Meaning: Refining Troponin Thresholds to Align Risks Between Spontaneous and Procedural Myocardial Infarction.. 84:478-481. 2024
Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis.. 84:276-294. 2024
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials.. 84:773-785. 2024
Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program.. 84:247-257. 2024
Anticoagulants in Subclinical Atrial Fibrillation: Beginning to Define the Treatment Paradigm.. 84:365-367. 2024
Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States.. 83:1990-1998. 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.. 84:27-40. 2024
Reflections on the Practice of Geriatric Cardiology After a Mid-Career Geriatrics Fellowship.. 83:1619-1622. 2024
Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.. 83:1082-1084. 2024
Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality.. 83:783-793. 2024
Global Burden of Cardiovascular Diseases and Risks, 1990-2022.. 82:2350-2473. 2023
Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) Study.. 82:2179-2192. 2023
Impact of Positron Emission Tomographic Myocardial Perfusion Imaging on Patient Selection for Revascularization.. 82:1662-1672. 2023
Cardiac Re-operation or Transcatheter Mitral Valve Replacement for Patients with Failed Mitral Prostheses.. 83:317-330. 2023
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.. 82:2087-2096. 2023
High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease.. 82:473-485. 2023
Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement.. 82:631-647. 2023
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.. 81:1697-1709. 2023
Stable Coronary Artery Disease in the Age of Geriatric Cardiology.. 81:1710-1713. 2023
Thromboprophylaxis in Patients With Fontan Circulation.. 81:374-389. 2023
Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.. 80:1516-1525. 2022
Malignant Left Ventricular Hypertrophy and Epidemiology 101.. 80:1526-1528. 2022
Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.. 79:2516-2525. 2022
Social Determinants of Health, Income, and Anticoagulation Outcomes.. 79:2514-2515. 2022
High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.. 79:1802-1813. 2022
Association of Left Atrial Structure and Function With Heart Failure in Older Adults.. 79:1549-1561. 2022
Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review.. 79:482-503. 2022
Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure.. 79:355-368. 2022
Risk-Adjusted, 30-Day Home Time After Transcatheter Aortic Valve Replacement as a Hospital-Level Performance Metric.. 79:132-144. 2022
Increasing Prevalence of Critical Limb Ischemia Hospitalizations With Distinct Mental Health Burden Among Younger Adults.. 78:2126-2128. 2021
Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults.. 78:1573-1583. 2021
Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.. 78:1587-1598. 2021
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.. 78:1550-1563. 2021
Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes.. 78:1242-1253. 2021
Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.. 78:1166-1187. 2021
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.. 78:421-433. 2021
Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults.. 77:3145-3156. 2021
Factors Predisposing to Survival After Resuscitation for Sudden Cardiac Arrest.. 77:2353-2362. 2021
Associations of Cardiac Mechanics With Exercise Capacity: The Multi-Ethnic Study of Atherosclerosis.. 78:245-257. 2021
Race/Ethnicity and Prevalence of Aortic Stenosis by Echocardiography in the Multi-Ethnic Study of Atherosclerosis.. 78:195-197. 2021
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.. 77:1977-1990. 2021
Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.. 77:1454-1469. 2021
Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?. 77:268-270. 2021
Reply: Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.. 78:e113-e115. 2021
Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review.. 76:2650-2670. 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel.. 76:2368-2378. 2020
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19.. 76:1965-1977. 2020
Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives.. 76:1577-1594. 2020
Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults.. 76:653-664. 2020
Primary Prevention Statins in Older Patients: The Good News or the Bad News First?. 76:28-30. 2020
Left Ventricular Recovery in Young Patients With Myocardial Infarction: How Much Is Enough?. 75:2816-2818. 2020
A Biomarker Approach to Understanding HFpEF.. 75:1296-1298. 2020
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.. 75:2372-2375. 2020
Precision Health Analytics With Predictive Analytics and Implementation Research: JACC State-of-the-Art Review.. 76:306-320. 2020
Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease.. 76:2226-2234. 2020
Sarcopenia in Older Adults Undergoing Transcatheter Aortic Valve Replacement.. 74:3178-3180. 2019
Sex and Race/Ethnicity Differences in Atrial Fibrillation.. 74:2812-2815. 2019
Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit With Early Revascularization.. 74:1645-1654. 2019
Ischemia on PET MPI May Identify Patients With Improvement in Angina and Health Status Post-Revascularization.. 74:1734-1736. 2019
Reply: Benefit of Primary Percutaneous Coronary Intervention in Elderly Patients With Cardiogenic Shock.. 74:824-825. 2019
Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events.. 74:330-341. 2019
High-Sensitivity Cardiac Troponin Assays Potentially Differentiate Acute From Chronic Myocardial Injury.. 73:2904-2905. 2019
Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.. 73:2705-2718. 2019
Deprescribing in Older Adults With Cardiovascular Disease.. 73:2584-2595. 2019
Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review Topic of the Week.. 73:2454-2464. 2019
Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock.. 73:1890-1900. 2019
Time to Get Going on Involving FITs in Clinical Trials.. 72:2802-2805. 2018
Differences in Risk of Sudden Cardiac Death Between Blacks and Whites.. 72:2431-2439. 2018
Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease.. 72:1227-1232. 2018
Multimorbidity in Older Adults With Cardiovascular Disease.. 71:2149-2161. 2018
Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.. 71:1921-1936. 2018
Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.. 71:2527-2536. 2018
Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.. 71:1-8. 2018
Data Sharing and Cardiology: Platforms and Possibilities.. 70:3018-3025. 2017
Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.. 70:2022-2035. 2017
Limitations of Treating Heart Rate as the Primary Outcome Determinant in Older Adults.. 70:1872-1874. 2017
Merits of Data Sharing: The Digitalis Investigation Group Trial.. 70:1825-1827. 2017
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants.. 70:558-568. 2017
Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.. 70:689-700. 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.. 69:2606-2618. 2017
Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.. 69:1683-1691. 2017
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.. 69:2054-2063. 2017
Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure.. 69:1129-1142. 2017
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.. 69:823-836. 2017
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.. 69:395-403. 2017
Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.. 69:244-246. 2017
Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.. 68:895-904. 2016
Longer-Lived Parents and Cardiovascular Outcomes: 8-Year Follow-Up In 186,000 U.K. Biobank Participants.. 68:874-5. 2016
The HFpEF Obesity Phenotype: The Elephant in the Room.. 68:200-3. 2016
Effect of Pulmonary Vascular Pressures on Long-Term Outcome in Patients With Primary Mitral Regurgitation.. 67:2952-61. 2016
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.. 67:1661-71. 2016
Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR.. 67:739-47. 2016
Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure.. 67:780-9. 2016
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.. 67:239-47. 2016
Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.. 67:291-9. 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).. 68:161-72. 2016
What to Expect From the Evolving Field of Geriatric Cardiology.. 66:1286-1299. 2015
Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry.. 66:917-26. 2015
Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.. 66:765-773. 2015
Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation: Challenges and Opportunities.. 65:2652-2659. 2015
Readmissions after carotid artery revascularization in the Medicare population.. 65:1398-408. 2015
Cardiac determinants of heterogeneity in fitness change in response to moderate intensity aerobic exercise training: the DREW study.. 65:1057-8. 2015
Which came first, the frailty or the heart disease?: exploring the vicious cycle.. 65:984-6. 2015
The QT interval is associated with incident cardiovascular events: the MESA study.. 64:2111-9. 2014
Clinical implications of chronic heart failure phenotypes defined by cluster analysis.. 64:1765-74. 2014
Sex steroid as a new oracle to predict cardiovascular risk.. 64:1811-3. 2014
Geriatric cardiology: a fellow's perspective.. 64:1401-3. 2014
Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.. 63:1441-8. 2014
Incidence of and risk factors for sick sinus syndrome in the general population.. 64:531-8. 2014
Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry).. 63:788-96. 2013
Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension.. 63:834-5. 2013
Heart failure with preserved ejection fraction: a heterogenous disorder with multifactorial pathophysiology.. 63:457-9. 2013
The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .. 62:2205-14. 2013
Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.. 62:1791-801. 2013
Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events.. 62:1267-1276. 2013
Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.. 62:584-92. 2013
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?. 61:1549-50. 2013
Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity.. 61:2288-95. 2013
Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis).. 61:1231-9. 2013
National trends in heart failure hospital stay rates, 2001 to 2009.. 61:1078-88. 2013
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.. 61:702-11. 2013
Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study.. 61:635-42. 2013
Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study.. 62:2112-20. 2013
Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.. 61:187-95. 2012
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.. 60:2504-12. 2012
Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults.. 60:2539-47. 2012
Relation between volume of exercise and clinical outcomes in patients with heart failure.. 60:1899-905. 2012
Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT.. 60:1809-16. 2012
Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial.. 60:208-15. 2012
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).. 60:200-7. 2012
Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death?. 58:1497-506. 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.. 58:395-401. 2011
Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).. 58:140-6. 2011
Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.. 57:1069-77. 2011
Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.. 58:291-7. 2011
Heart failure with a preserved ejection fraction: what is in a name?. 58:275-7. 2011
Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis.. 56:702-11. 2010
Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.. 55:441-50. 2010
Geriatric conditions and subsequent mortality in older patients with heart failure.. 55:309-16. 2010
Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy.. 54:832-7. 2009
Biomarkers for prognostication after acute coronary syndromes: new times and statistics.. 54:365-7. 2009
Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).. 54:1176-84. 2009
Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.. 52:644-51. 2008
Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction.. 51:1384-92. 2008
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.. 51:810-5. 2008
Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction.. 51:716-23. 2008
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography.. 49:378-402. 2007
Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis.. 48:2285-92. 2006
Cystatin-C and mortality in elderly persons with heart failure.. 45:268-71. 2005
Renal insufficiency as an independent predictor of mortality among women with heart failure.. 44:1593-600. 2004
Task force 2: Investigator participation in clinical research.. 44:1729-36. 2004
Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure.. 39:1170-4. 2002
The relationship between vascular wall shear stress and flow-mediated dilation: endothelial function assessed by phase-contrast magnetic resonance angiography.. 38:1859-65. 2001
Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations.. 33:1956-63. 1999
Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody.. 23:1031-7. 1994
Effects of steal-prone anatomy on intraoperative myocardial ischemia. The SPI Research Group.. 20:1205-12. 1992
The Association of Frailty with Risk for Institutionalization in High Need High Risk Older Veterans with Aortic Stenosis. 2022
Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review 2020
Primary Prevention Statins in Older Patients: The Good News or the Bad News First? 2020
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants 2017
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants 2017

Clin-STAR Database

Journal of the American College of Cardiology Journal

Overview

publication venue for

Identity

International Standard Serial Number (ISSN)